FrancophonIA/ELRC3.0 huggingface dataset:
English: 25% of the insulin lispro in Humalog Mix25 KwikPen is dissolved in water and it works more quickly than normal human insulin because the insulin molecule has been changed slightly.
Croatian: 25% inzulina lispro u lijeku Humalog Mix25 KwikPen otopljeno je u vodi i djeluje brže od običnog humanog inzulina jer je molekula inzulina malo promijenjena.
English: Your doctor may tell you to use Humalog Mix50 as well as a longer-acting insulin.
Croatian: Liječnik Vam može savjetovati da primjenjujete Humalog Mix50 zajedno s inzulinom duljeg djelovanja.
English: MARKETING AUTHORISATION NUMBER EU/1/96/007/035
Croatian: 12. BROJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/96/007/035
English: Your doctor may tell you to use Humalog as well as a longer-acting insulin.
Croatian: Liječnik Vam može savjetovati da primjenjujete Humalog zajedno s inzulinom duljeg djelovanja.
English: MARKETING AUTHORISATION NUMBER EU/1/96/007/005
Croatian: 12. BROJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/96/007/005
English: MARKETING AUTHORISATION NUMBERS EU/1/96/007/002
Croatian: 12. BROJEVI ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/96/007/002
English: Important information about some of the ingredients of Humalog Junior KwikPen This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodiumfree'.
Croatian: Važne informacije o nekim sastojcima lijeka Humalog Junior KwikPen Ovaj lijek sadrži manje od 1 mmol natrija (23 g) po dozi, tj. zanemarive količine natrija.
English: Do not transfer insulin from your Humalog 200 units/ml KwikPen to any other insulin delivery devices like insulin infusion pumps.
Croatian: 200 jedinica/ml KwikPen brizgalice ne smije se prebacivati ni u jedno drugo pomagalo za primjenu inzulina, poput inzulinskih infuzijskih pumpi.
English: MARKETING AUTHORISATION NUMBER EU/1/96/007/034
Croatian: 12. BROJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/96/007/034
English: Keep your Humalog Mix25 KwikPen in use at room temperature (15° - 30°C) and discard after 28 days.
Croatian: Humalog Mix25 KwikPen koji koristite čuvati na sobnoj temperaturi (15°C - 30°C) i baciti nakon
English: MARKETING AUTHORISATION NUMBER EU/1/96/007/031
Croatian: 12. BROJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/96/007/031
English: How to store Humalog Mix25 KwikPen
Croatian: Kako čuvati Humalog Mix25 KwikPen
English: 25% of the insulin lispro in Humalog Mix25 is dissolved in water and it works more quickly than normal human insulin because the insulin molecule has been changed slightly.
Croatian: 25% inzulina lispro u lijeku Humalog Mix25 otopljeno je u vodi i djeluje brže od običnog humanog inzulina jer je molekula inzulina malo promijenjena.
English: USER MANUAL Humalog 200 units/ml KwikPen, solution for injection in a pre-filled pen insulin lispro
Croatian: PRIRUČNIK ZA UPORABU Humalog 200 jedinica/ml KwikPen, otopina za injekciju u napunjenoj brizgalici inzulin lispro
English: What Humalog Mix25 100 units/ml suspension for injection in vial looks like and contents of the pack
Croatian: Kako Humalog Mix25 100 jedinica/ml suspenzija za injekciju u ulošku izgleda i sadržaj pakiranja
English: Type I glass cartridges, sealed with halobutyl disc seals and plunger heads and secured with aluminium seals.
Croatian: Stakleni ulošci (staklo tipa I) zatvoreni zaštitnom halobutilnom pločicom i bromobutilnom glavom klipa te osigurani aluminijskim zaštitnim zatvaračem.
English: NAME OF THE MEDICINAL PRODUCT Humalog 200 units/ml KwikPen, solution for injection in a pre-filled pen Insulin lispro
Croatian: NAZIV LIJEKA Humalog 200 jedinica/ml KwikPen, otopina za injekciju u napunjenoj brizgalici
English: 50% of the insulin lispro in Humalog Mix50 KwikPen is dissolved in water and it works more quickly than normal human insulin because the insulin molecule has been changed slightly.
Croatian: 50% inzulina lispro u lijeku Humalog Mix50 KwikPen otopljeno je u vodi i djeluje brže od običnog humanog inzulina jer je molekula inzulina malo promijenjena.
English: Humalog 100 units/ml, solution for injection in vial insulin lispro
Croatian: Humalog 100 jedinica/ml, otopina za injekciju u bočici inzulin lispro
English: MARKETING AUTHORISATION NUMBERS EU/1/96/007/004
Croatian: 12. BROJEVI ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/96/007/004
English: • Always keep spare syringes and a spare vial of Humalog, or a spare pen and cartridges, in case you lose your pen or cartridges or they get damaged.
Croatian: • Uvijek sa sobom nosite rezervne štrcaljke i rezervnu bočicu lijeka Humalog, odnosno rezervnu brizgalicu i uloške, u slučaju da se brizgalica i ulošci koje koristite izgube ili oštete.
English: 50% of the insulin lispro in Humalog Mix50 is dissolved in water and it works more quickly than normal human insulin because the insulin molecule has been changed slightly.
Croatian: 50% inzulina lispro u lijeku Humalog Mix50 otopljeno je u vodi i djeluje brže od običnog humanog inzulina jer je molekula inzulina malo promijenjena.
English: NAME OF THE MEDICINAL PRODUCT Humalog Mix25 100 units/ml KwikPen, suspension for injection in a pre-filled pen 25% insulin lispro and 75% insulin lispro protamine suspension
Croatian: Humalog Mix25 100 jedinica/ml KwikPen, suspenzija za injekciju u napunjenoj brizgalici 25% inzulin lispro i 75% suspenzija inzulina lispro s protaminom
English: Important information about some of the ingredients of Humalog Mix25 KwikPen This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodiumfree'.
Croatian: Važne informacije o nekim sastojcima lijeka Humalog Mix25 KwikPen Ovaj lijek sadrži manje od 1 mmol natrija (23 g) po dozi, tj. zanemarive količine natrija.
English: • Always keep a spare pen and cartridges, in case you lose your pen or cartridges or they get damaged.
Croatian: • Uvijek sa sobom nosite rezervnu brizgalicu i uloške, u slučaju da se brizgalica i ulošci koje koristite izgube ili oštete.
English: Humalog 200 units/ml KwikPen, solution for injection Insulin lispro
Croatian: Humalog 200 jedinica/ml KwikPen, otopina za injekciju u napunjenoj brizgalici inzulin lispro
English: MARKETING AUTHORISATION NUMBER EU/1/96/007/036
Croatian: 12. BROJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/96/007/036
English: The suspension is contained in type I flint glass vials, sealed with butyl or halobutyl stoppers and secured with aluminium seals.
Croatian: Suspenzija se nalazi u staklenoj bočici (kremeno staklo tipa I), zatvorenoj gumenim čepom (butilna ili halobutilna guma) i zaštitnim aluminijskim zatvaračem.
English: MARKETING AUTHORISATION NUMBERS EU/1/96/007/006
Croatian: 12. BROJEVI ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/96/007/006
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Humalog Mix25 100 units/ml suspension for injection in vial 25% insulin lispro and 75% insulin lispro protamine suspension Subcutaneous use
Croatian: NAZIV LIJEKA I PUT PRIMJENE LIJEKA Humalog Mix25 100 jedinica/ml suspenzija za injekciju u ulošku 25% inzulin lispro i 75% suspenzija inzulina lispro s protaminom
English: If you take more Humalog Mix25 than you need If you take more Humalog Mix25 than you need, a low blood sugar may occur.
Croatian: Ako primijenite više lijeka Humalog Mix25 nego što ste trebali, može doći do pada razine šećera u krvi.
English: • You should normally inject Humalog Mix50 within 15 minutes of a meal.
Croatian: Doziranje • Humalog Mix50 u pravilu trebate injicirati unutar 15 minuta prije obroka.
English: 2 pens of 3 mL.
Croatian: 2 brizgalice od 3 ml
English: Humalog 100 units/ml Junior KwikPen, solution for injection in a pre-filled pen.
Croatian: Humalog 100 jedinica/ml Junior KwikPen, otopina za injekciju u napunjenoj brizgalici inzulin lispro
English: Renal impairment Insulin requirements may be reduced in the presence of renal impairment.
Croatian: Oštećenje bubrežne funkcije Potrebe za inzulinom mogu biti smanjene u slučaju oštećenja bubrežne funkcije.
English: Instructions for Use Humalog 100 units/ml Junior KwikPen, solution for injection in a pre-filled pen insulin lispro
Croatian: Uputa o lijeku: Informacije za korisnika Humalog 100 jedinica/ml KwikPen, otopina za injekciju u napunjenoj brizgalici inzulin lispro
English: Keep your Humalog Mix50 KwikPen in use at room temperature (15° - 30°C) and discard after 28 days.
Croatian: Humalog Mix50 KwikPen koji koristite čuvati na sobnoj temperaturi (15°C - 30°C) i baciti nakon
English: Humalog KwikPen is available in two strengths.The Humalog 200 units/ml KwikPen (and Humalog 100 units/ml KwikPen, see separate SmPC) delivers 1 - 60 units in steps of 1 unit in a single injection.
Croatian: Brizgalicom Humalog 200 jedinica/ml KwikPen (i brizgalicom Humalog 100 jedinica/ml KwikPen, vidjeti zaseban sažetak opisa svojstava lijeka)
English: What Humalog Mix50 100 units/ml KwikPen, suspension for injection contains - The active substance is insulin lispro.
Croatian: Sadržaj pakiranja i druge informacije Što Humalog Mix50 100 jedinica/ml KwikPen suspenzija za injekciju sadrži - Djelatna tvar je inzulin lispro.
English: You can see how much Humalog is left by looking at the gauge on the side of the cartridge.
Croatian: Možete vidjeti koliko je inzulina preostalo tako da držite KwikPen brizgalicu iglom okrenutom prema gore.
English: Do not use Humalog 200 units/ml KwikPen solution for injection in an insulin infusion pump.
Croatian: Humalog 200 jedinica/ml KwikPen otopina za injekciju ne smije se primjenjivati u inzulinskoj infuzijskoj pumpi.
English: Humalog Mix50 100 units/ml KwikPen, suspension for injection is a white, sterile suspension and contains 100 units of insulin lispro in each millilitre (100 units/ml) suspension for injection.
Croatian: Humalog Mix50 100 jedinica/ml KwikPen suspenzija za injekciju je bijela sterilna suspenzija, koja sadrži 100 jedinica inzulina lispro u jednom mililitru (100 jedinica/ml) suspenzije za injekciju.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Humalog Mix50 100 units/ml suspension for injection in cartridge 50% insulin lispro and 50% insulin lispro protamine suspension Subcutaneous use
Croatian: NAZIV LIJEKA I PUT PRIMJENE LIJEKA Humalog Mix50 100 jedinica/ml suspenzija za injekciju u ulošku 50% inzulin lispro i 50% suspenzija inzulina lispro s protaminom
English: What Humalog Mix25 100 units/ml KwikPen, suspension for injection contains - The active substance is insulin lispro.
Croatian: Sadržaj pakiranja i druge informacije Što Humalog Mix25 100 jedinica/ml KwikPen suspenzija za injekciju sadrži - Djelatna tvar je inzulin lispro.
English: What Humalog Mix50 100 units/ml suspension for injection in cartridge looks like and contents of the pack
Croatian: Kako Humalog Mix50 100 jedinica/ml suspenzija za injekciju u ulošku izgleda i sadržaj pakiranja
English: • not taking your Humalog or other insulin;
Croatian: Hiperglikemija može nastupiti ako: • ne primijenite Humalog ili drugi inzulin,
English: Important information about some of the ingredients of Humalog This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodiumfree'.
Croatian: Važne informacije o nekim sastojcima lijeka Humalog Ovaj lijek sadrži manje od 1 mmol natrija (23 g) po dozi, tj. zanemarive količine natrija.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Humalog 100 units/ml solution for injection in vial Insulin lispro
Croatian: NAZIV LIJEKA I PUT PRIMJENE LIJEKA Humalog 100 jedinica/ml otopina za injekciju u ulošku inzulin lispro
English: NAME OF THE MEDICINAL PRODUCT Humalog Mix50 100 units/ml suspension for injection in cartridge 50% insulin lispro and 50% insulin lispro protamine suspension
Croatian: Humalog Mix50 100 jedinica/ml suspenzija za injekciju u ulošku 50% inzulin lispro i 50% suspenzija inzulina lispro s protaminom
English: Humalog Mix25 100 units/ml, suspension for injection in vial insulin lispro
Croatian: Uputa o lijeku: Informacije za korisnika Humalog Mix25 100 jedinica/ml, suspenzija za injekciju u ulošku inzulin lispro
English: If you take more Humalog Mix50 than you need If you take more Humalog Mix50 than you need, a low blood sugar may occur.
Croatian: Ako primijenite više lijeka Humalog Mix50 nego što ste trebali, može doći do pada razine šećera u krvi.
English: Humalog Mix25 100 units/ml suspension for injection is a white, sterile suspension and contains 100 units of insulin lispro in each millilitre (100 units/ml) suspension for injection.
Croatian: Humalog Mix25 100 jedinica/ml suspenzija za injekciju je bijela sterilna suspenzija, koja sadrži 100 jedinica inzulina lispro u jednom mililitru (100 jedinica/ml) suspenzije za injekciju.
English: Marketing Authorisation Holder and Manufacturer Humalog Mix50 100 units/ml suspension for injection in cartridge is made by:
Croatian: Humalog Mix50 100 jedinica/ml suspenziju za injekciju u ulošku proizvodi:
English: Humalog Mix50 100 units/ml suspension for injection is a white, sterile suspension and contains 100 units of insulin lispro in each millilitre (100 units/ml) suspension for injection.
Croatian: Humalog Mix50 100 jedinica/ml suspenzija za injekciju je bijela sterilna suspenzija, koja sadrži 100 jedinica inzulina lispro u jednom mililitru (100 jedinica/ml) suspenzije za injekciju.
English: Important information about some of the ingredients of Humalog Mix25 This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodiumfree'.
Croatian: Važne informacije o nekim sastojcima lijeka Humalog Mix25 Ovaj lijek sadrži manje od 1 mmol natrija (23 g) po dozi, tj. zanemarive količine natrija.
English: Important information about some of the ingredients of Humalog Mix50 This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodiumfree'.
Croatian: Važne informacije o nekim sastojcima lijeka Humalog Mix50 Ovaj lijek sadrži manje od 1 mmol natrija (23 g) po dozi, tj. zanemarive količine natrija.
English: The Humalog Junior KwikPen comes in a pack of 1or 5 pre-filled pens or multipacks of 2 x 5 pre-filled pens.
Croatian: Humalog Junior KwikPen dostupan je u pakiranju od 1 ili 5 napunjenih brizgalica ili u višestrukim pakiranjima od
English: Important information about some of the ingredients of Humalog KwikPen This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodiumfree'.
Croatian: Važne informacije o nekim sastojcima lijeka Humalog KwikPen Ovaj lijek sadrži manje od 1 mmol natrija (23 g) po dozi, tj. zanemarive količine natrija.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU
English: How to store Humalog Junior KwikPen Contents of the pack and other information
Croatian: Kako čuvati Humalog Junior KwikPen Lijek čuvajte izvan pogleda i dohvata djece.
English: Marketing Authorisation Holder and Manufacturer Humalog Mix25 100 units/ml suspension for injection in cartridge is made by:
Croatian: Humalog Mix25 100 jedinica/ml suspenziju za injekciju u ulošku proizvodi:
English: Do not transfer insulin from your Humalog 200 units/ml KwikPen to a syringe.
Croatian: Inzulin iz Humalog 200 jedinica/ml KwikPen brizgalice ne smije se prebacivati u štrcaljku.
English: Humalog Mix25 100 units/ KwikPen, suspension for injection is a white, sterile suspension and contains 100 units of insulin lispro in each millilitre (100 units/ml) suspension for injection.
Croatian: Humalog Mix25 100 jedinica/ml KwikPen suspenzija za injekciju je bijela sterilna suspenzija, koja sadrži 100 jedinica inzulina lispro u jednom mililitru (100 jedinica/ml) suspenzije za injekciju.
English: Humalog 100 units/ml, solution for injection in cartridge insulin lispro
Croatian: Humalog 100 jedinica/ml KwikPen, otopina za injekciju u napunjenoj brizgalici inzulin lispro
English: Marketing Authorisation Holder and Manufacturer Humalog 100 units/ml KwikPen, solution for injection is made by:
Croatian: Humalog 100 jedinica/ml KwikPen otopinu za injekciju proizvodi:
English: What Humalog 200 units/ml KwikPen solution for injection contains - The active substance is insulin lispro.
Croatian: Sadržaj pakiranja i druge informacije Što Humalog 200 jedinica/ml KwikPen otopina za injekciju sadrži - Djelatna tvar je inzulin lispro.
English: NAME OF THE MEDICINAL PRODUCT Humalog Mix25 100 units/ml suspension for injection in vial 25% insulin lispro and 75% insulin lispro protamine suspension
Croatian: Humalog Mix25 100 jedinica/ml suspenzija za injekciju u ulošku 25% inzulin lispro i 75% suspenzija inzulina lispro s protaminom
English: Marketing Authorisation Holder and Manufacturer Humalog 100 units/ml, solution for injection in vial is made by:
Croatian: Humalog 100 jedinica/ml otopinu za injekciju u ulošku proizvodi:
English: Do not use this medicine if you notice the solution is coloured or it has solid pieces in it. You must use it only if it looks like water.
Croatian: Ovaj lijek se ne smije upotrijebiti ako primijetite da je otopina obojena ili da sadrži krute čestice.
English: How to store Humalog 200 units/ml KwikPen
Croatian: Moguće nuspojave Kako čuvati Humalog 200 jedinica/ml KwikPen
English: It is important to prime your Pen so that it will work correctly.
Croatian: Sačuvati Baciti normalne uporabe i time se osigurava da će brizgalica pravilno raditi.
English: Do not reuse or share needles with other people.. You may give an infection to them or get an infection from them.
Croatian: Igle ne smijete ponovno upotrijebiti niti dijeliti s drugim osobama.
English: If the target blood
Croatian: Ako se krvni
English: It is available as tablets (20 mg, 40 mg and 80 mg).
Croatian: Dostupan je u tabletama (20 mg, 40 mg i 80 mg).
English: It also allows the heart to pump blood more easily, which can help to reduce the risk of future cardiovascular problems
Croatian: Također omogućuje srcu da lakše pumpa krv, što pomaže pri smanjivanju rizika od budućih kardiovaskularnih problema.
English: Telmisartan Teva Pharma is also used to prevent cardiovascular problems (problems with the heart and blood vessels) such as heart attacks or strokes.
Croatian: Telmisartan Teva Pharma se također koristi za sprječavanje kardiovaskularnih problema (problema sa srcem i krvnim žilama) poput srčanog zastoja ili moždanog udara).
English: For the treatment of essential hypertension, the usual recommended dose of Telmisartan Teva Pharma is 40 mg once a day, but some patients may benefit from using a 20-mg dose.
Croatian: Za terapiju esencijalne hipertenzije, uobičajena preporučena doza lijeka Telmisartan Teva Pharma iznosi 40 mg jednom na dan, no pojedini bolesnici mogu imati koristi od doze od 20-mg.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Telmisartan Teva Pharma.
Croatian: Objašnjava kako je Odbor za lijekove za humanu uporabu (CHMP) ocijenio lijek da bi donio svoje mišljenje u korist izdavanja odobrenja za stavljanje lijeka u promet i svoje preporuke za uporabu lijeka Telmisartan Teva Pharma.
English: pressure is not reached, the dose can be increased to 80 mg, or another medicine for hypertension can be added, such as hydrochlorothiazide.
Croatian: tlak ne može dostatno kontrolirati, doza se može povećati na 80 mg jedanput na dan ili se mogu dodati drugi antihipertenzivi, poput hidroklorotiazida.
English: The active substance in Telmisartan Teva Pharma, telmisartan, is an ‘angiotensin II receptor antagonist', which means that it blocks the action of a hormone in the body called angiotensin II.
Croatian: Telmisartan, djelatna tvar u lijeku Telmisartan Teva Pharma je „antagonist receptora angiotenzina II”, što znači da ova tvar blokira djelovanje hormona u tijelu naziva angiotenzin II.
English: Telmisartan Teva Pharma is a ‘generic medicine'.
Croatian: Telmisartan Teva Pharma je "generički lijek".
English: This is a summary of the European Public Assessment Report (EPAR) for Telmisartan Teva Pharma.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Telmisartan Teva Pharma.
English: Because Telmisartan Teva Pharma is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Croatian: Budući da je Telmisartan Teva Pharma generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
English: The European Commission granted a marketing authorisation valid throughout the EU for Telmisartan Teva Pharma on 3 October 2011.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za lijek Telmisartan Teva Pharma na snazi u Europskoj uniji od 3. listopada 2011.
English: Patients with mild or moderately reduced liver function should not receive doses higher than 40 mg a day
Croatian: Bolesnici s blago do umjereno smanjenom funkcijom jetre ne smiju primiti doze veće od 40 mg na dan.
English: The doctor should monitor the patient's blood pressure closely when starting Telmisartan Teva Pharma, and may decide to adjust the patient's blood pressure-lowering medication.
Croatian: Prilikom počinjanja terapije lijekom Telmisartan Teva Pharma, liječnik treba pratiti pažljivo krvni tlak bolesnika, te može donijeti odluku o prilagođavanju terapije koja služi za snižavanje krvnoga tlaka bolesnika.
English: Telmisartan Teva Pharma is a medicine that contains the active substance telmisartan.
Croatian: Telmisartan Teva Pharma je lijek koji sadrži djelatnu tvar telmisartan.
English: Other information about Telmisartan Teva Pharma:
Croatian: Ostale informacije o lijeku Telmisartan Teva Pharma:
English: Because Telmisartan Teva Pharma is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Micardis.
Croatian: Budući da je Telmisartan Teva Pharma generički lijek, ispitivanja na bolesnicima bila su ograničena na ispitivanja za utvrđivanje da je lijek bioekvivalentan referentnom lijeku Micardis.
English: What are the benefit and risk of Telmisartan Teva Pharma?
Croatian: Koje su koristi i rizici lijeka Telmisartan Teva Pharma?
English: The CHMP concluded that, in accordance with EU requirements, Telmisartan Teva Pharma has been shown to have comparable quality and to be bioequivalent to Micardis.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) pri Agenciji zaključio je kako je, u skladu s preduvjetima EU-a, lijek Telmisartan Teva Pharma posjeduje usporedivu kvalitetu te je bioekvivalentan s lijekom Micardis.
English: The full EPAR for Telmisartan Teva Pharma can be found on the Agency's website: EMA website/Find medicine/Human medicines/European Public Assessment Reports.
Croatian: Cjeloviti EPAR za lijek Telmisartan Teva Pharma nalazi se na internetskim stranicama Agencije: EMA website/Find medicine/Human medicines/European Public Assessment Reports Više informacija o terapiji lijekom Telmisartan Teva Pharma pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svom liječniku ili ljekarniku.
English: Telmisartan Teva Pharma is used to treat essential hypertension (high blood pressure) in adults.
Croatian: Telmisartan Teva Pharma koristi se za liječenje esencijalne hipertenzije (visokog krvnog tlaka) u odraslih. „Esencijalno” znači da ne postoji očiti uzrok hipertenzije.
English: Why has Telmisartan Teva Pharma been approved?
Croatian: Zašto je Telmisartan Teva Pharma odobren?
English: The Committee recommended that Telmisartan Teva Pharma be given marketing authorisation.
Croatian: Odbor je preporučio izdavanje odobrenja za stavljanje u promet lijeka Telmisartan Teva Pharma.
English: This means that Telmisartan Teva Pharma is similar to a ‘reference medicine' already authorised in the European Union (EU) called Micardis.
Croatian: To znači da je Telmisartan Teva Pharma sličan „referentnom lijeku” koji je već odobren u Europskoj uniji pod nazivom Micardis Više informacija o generičkim lijekovima potražite u dokumentu s pitanjima i odgovorima ovdje.
English: How is Telmisartan Teva Pharma used?
Croatian: Kako se Telmisartan Teva Pharma koristi?
English: What is Telmisartan Teva Pharma used for?
Croatian: Za što se Telmisartan Teva Pharma koristi?